PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 53 filers reported holding PROQR THRAPEUTICS N V in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OneDigital Investment Advisors LLC | 15,300 | $24,786 | 0.00% |
| Centiva Capital, LP | 23,160 | $37,519 | 0.00% |
| MACQUARIE GROUP LTD | 620,000 | $1,004,000 | 0.00% |
| Csenge Advisory Group | 10,000 | $16,200 | 0.00% |
| Vanguard Personalized Indexing Management, LLC | 21,429 | $34,715 | 0.00% |
| Renaissance Technologies | 200,499 | $325 | 0.00% |
| WELLS FARGO & COMPANY/MN | 10,996 | $17,814 | 0.00% |
| NORTHERN TRUST CORP | 17,420 | $28,221 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 5,912 | $9 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,892 | $6,305 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 36,293 | $58,794 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 611,661 | $990,891 | 0.00% |
| UBS Group AG | 4,681 | $7,583 | 0.00% |
| DEUTSCHE BANK AG\ | 385,208 | $624,037 | 0.00% |
| MORGAN STANLEY | 495,516 | $802,736 | 0.00% |
| Invesco Ltd. | 19,122 | $30,978 | 0.00% |
| TRUIST FINANCIAL CORP | 10,000 | $16,200 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 20,550 | $33,291 | 0.00% |
| BlackRock Inc. | 3,945 | $6,391 | 0.00% |
External links
This page lists PROQR THRAPEUTICS N V's shareholders in Q2 2023. To view PROQR THRAPEUTICS N V's shareholder history, click here.